Kleefstra syndrome
Human disease

Kleefstra syndrome, also known as 9q34 deletion syndrome, is a rare genetic disorder. Terminal deletions of chromosome 9q34 have been associated with childhood hypotonia, distinctive facial appearance and intellectual disability. Most individuals fall within the moderate to severe range of intellectual disability, while a minority shows mild delays and have total IQ scores within the low-normal range. Typical facial features include arched eyebrows, microcephaly, midface hypoplasia, a prominent jaw and a pouting lower lip. Affected individuals often exhibit speech impairments, including significant speech delays. Severe expressive language delays with limited speech production are common; however, general language development is often more advanced, enabling non-verbal communication. Other common features include epilepsy, congenital and urogenital anomalies, microcephaly, obesity, and psychiatric disorders. Through analysis of chromosomal breakpoints, as well as gene sequencing in suggestive cases, Kleefstra and colleagues identified EHMT1 as the causative gene: this gene is responsible for producing the protein histone methyltransferase whose function is to alter histones. Histone methyltransferases are also important in deactivating certain genes needed for proper growth and development. Moreover, a frameshift, missense, or nonsense error in the coding sequence of EHMT1 can result in this condition in an individual.
Begin with the source’s own compact description: “Kleefstra syndrome” is human disease. The dossier treats that line as a proposition to test through Kleefstra, syndrome and Human, not as a finished interpretation.
Why this record matters
The phrase “human disease” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Aug 12, 2026. The linked authority identifier is Q4646476. None of the 1 selected statements returned an explicit reference.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Kleefstra syndrome”, its source revision and the description used here.
- Expand the search: follow Kleefstra syndrome primary sources, Kleefstra syndrome archive and Kleefstra research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Kleefstra syndrome”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Kleefstra syndrome” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.